Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 31, Issue Suppl 3
58 KEYNOTE-826: Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Late breaking abstracts
Cervical cancer
58 KEYNOTE-826: Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer
Free
Online download statistics by month:
Online download statistics by month: October 2021 to April 2024
Abstract
Full
Pdf
Oct 2021
50
0
11
Nov 2021
192
0
22
Dec 2021
46
0
15
Jan 2022
235
0
20
Feb 2022
223
0
16
Mar 2022
70
0
29
Apr 2022
21
0
14
May 2022
68
0
24
Jun 2022
61
0
12
Jul 2022
53
0
15
Aug 2022
43
0
12
Sep 2022
54
0
14
Oct 2022
46
0
11
Nov 2022
78
0
22
Dec 2022
52
0
9
Jan 2023
51
0
7
Feb 2023
110
0
9
Mar 2023
75
0
14
Apr 2023
49
0
6
May 2023
52
0
11
Jun 2023
54
0
19
Jul 2023
44
0
5
Aug 2023
63
0
13
Sep 2023
57
0
4
Oct 2023
46
0
0
Nov 2023
46
0
9
Dec 2023
40
0
2
Jan 2024
38
0
14
Feb 2024
41
0
7
Mar 2024
60
0
6
Apr 2024
16
0
1
Total
2134
0
373
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF